CYCLERION THERAPEUTICS ANNOUNCES STRATEGIC AGREEMENT WITH MEDSTEER AND PROGRESS TOWARD INITIATING PHASE 2 PROOF-OF-CONCEPT STUDY FOR CYC-126 IN TREATMENT-RESISTANT DEPRESSION

Reuters · 4d ago

Please log in to view news